Can B Corp. CANB
0.02 0.00 (+0.00%)
Jan 15, 2026, 9:30 AM EST
0.0144 Day range 0.0195
0.49 52-week range 15.75
- Market cap
- 1.03M
- Revenue (ttm)
- 3.09M
- EPS (ttm)
- -0.379
- Shares out
- 1.90M
- P/E ratio
- 0.21
- Forward P/E
- 27.00
- Volume
- 658.95K
- Avg volume
- 2.57K
- Open
- 0.016
- Previous close
- 0.01917
- Day's range
- 0.0144 – 0.0195
- 52-week range
- 0.49 – 15.75
- Beta
- 0.42
- Analysts
- Buy
- Price target
- 1.20 (+6159.8%)
No chart data for this range yet.
Key statistics
- Enterprise value
- 234.51M
- PEG ratio
- 0.00
- Price / sales
- 0.33
- Price / book
- 270.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 315.80%
- Free cash flow
- -3.54M
- Total cash
- 190.53K
- Total debt
- 6.44M
- Return on equity
- -218.25%
- Short % of float
- 0.00%
- 50-day average
- 7.38
- 200-day average
- 8.30
Analyst view
Consensus: buy
Buy
Price target (mean) 1.20
Ratings (-1m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.05.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | 0.00 | -0.05 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.04 | — | — |
| May 20, 2024 | Mar 1, 2024 | 0.00 | -0.13 | — | — |
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -0.36 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.37 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2021 | Greenridge Global | init | — | Buy |
About Can B Corp.
Can B Corp. produces and sells cannabidiol (CBD) based products in the United States. It provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates through its Website and vending machines, and other medical professionals. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- United States
- Website
- canbcorp.com
News
Your note
Sign in to keep a note on CANB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALFONSI MARCO | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 27, 2018 | 59,231,400 |
| DILLEY CARL E | Director | Purchase | Feb 8, 2018 | 4,085,030 |
| HEGGENHOUGEN ROLV E | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 29, 2017 | 0 |
| MCKENZIE WEBSTER, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 1, 2019 | 61,402,200 |
| ROLV HEGGENHOUGEN | Director | Sale | Dec 20, 2018 | 68,695,700 |